Inhibition of Protein Tyrosine Phosphatase 1B by Prenylated Isoflavonoids Isolated from the Stem Bark of Erythrina addisoniae [1]

Abstract

It has been suggested that protein tyrosine phosphatase 1B (PTP1B) inhibitors might be a therapeutic target for the treatment of type 2 diabetes and obesity. A bioassay-guided phytochemical study of the EtOAc extract of the stem bark of Erythrina addisoniae (Leguminosae) resulted in the identification of a new PTP1B inhibitory compound, 5,2′,4′-trihydroxy-6-(γ,γ-dimethylallyl)-2′′′,2′′′-dimethyldihydropyrano[5′′′,6′′′]isoflavanone (6), along with five known prenylated isoflavonoids, orientanol E (1), senegalensin (2), warangalone (3), warangalone 4′-methyl ether (4) and 2,3-dihydroauriculatin (5). Compounds 1, 5 and 6 inhibited PTP1B with IC₅₀ values ranging from 2.6 ± 0.5 to 10.1 ± 0.3 µM. Our results indicate that hydroxylation at both 2′- and 4′-positions in the B-ring and cyclization between a hydroxy group at C-7 and one of the prenyl groups at C-6 or C-8 in the A-ring may be important for activity. Thus, compounds 5 and 6 could be a new class of natural PTP1B inhibitors.

1 Part 47 in the series Erythrina Studies. For part 46 see reference [6]

References

• 1 Johnson T O, Ermolieff J, Jirousek M R. Protein tyrosine phosphatase 1B inhibitors for diabetes.  Nat Rev Drug Discov. 2002;  1 696-709
• 2 Ahmad F, Azevedo J J, Cortright R, Dohm G, Goldstein B. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.  J Clin Invest. 1997;  100 449-58
• 3 Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy A L. et al . Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.  Science. 1999;  283 1544-8
• 4 Asante-Appiah E, Kennedy B P. Protein tyrosine phosphatases: the quest for negative regulators of insulin action.  Am J Physiol Endocrinol Metab. 2003;  284 E663-70
• 5 Oliver-Bever B. Medicinal plants in tropical West Africa. New York; Cambridge University Press 1986: p 100
• 6 Fomum Stephen F T, Njamen D, Nde C BM, Wanji J, Zierau O, Fomum Z T. et al .Estrogenic effects of the ethyl-acetate extract of the stem bark of Erythrina lysistemon Hutch (Fabaceae). Phytomedicine, in press
• 7 Talla E, Njamen D, Mbafor J T, Fomum Z T, Kamanyi A, Mbanya J C. et al . Warangalone, the isoflavonoid anti-inflammatory principle of E. addisoniae stem bark.  J Nat Prod. 2003;  66 891-3
• 8 Tanaka H, Tanaka T, Hosoya A, Kitade Y, Etoh H. Three isoflavanones from Erythrina orientalis .  Phytochemistry. 1998;  48 355-7
• 9 Wandji J, Nkengfack A E, Fomum Z T, Ubillas R, Killday K B, Tempesta M S. A new prenylated isoflavone and long chain esters from two Erythrina species.  J Nat Prod. 1990;  53 1425-9
• 10 Tanaka H, Doi M, Etoh H, Watanabe N, Shimizu H, Hirata M. et al . Revised structures for senegalensin and euchrenone b10.  J Nat Prod. 2001;  64 1336-40
• 11 Singhal A K, Sharma R P, Thyagarajan G, Herz W, Govindan S V. New prenylated isoflavones and a prenylated dihydroflavonol from Millettia pachycarpa .  Phytochemistry. 1980;  19 929-34
• 12 Taylor R B, Corley D G, Tempesta M S, Fomum Z T, Ayafor J F, Wandji J. 2,3-Dihydroauriculatin, a new prenylated isoflavanone from Erythrina senegalensis. Application of the selective INEPT technique.  J Nat Prod. 1986;  49 670-3
• 13 Mizuno M, Matsuura N, Iinuma M, Tanaka T, Phengklai C. Isoflavones from stems of Euchresta horsfieldii .  Phytochemistry. 1990;  29 2675-7
• 14 Na M, Yang S, He L, Oh H, Oh W K, Kim B Y. et al . Inhibition of protein tyrosine phosphatase 1B by ursane-type triterpenes isolated from Symplocos paniculata .  Planta Med. 2006;  72 261-3
• 15 Cui L, Na M, Oh H, Bae E Y, Jeong D G, Ryu S E. et al . Protein tyrosine phosphatase 1B inhibitors from Morus root bark.  Bioorg Med Chem Lett. 2006;  16 1426-9

1 Part 47 in the series Erythrina Studies. For part 46 see reference [6]

2 These authors contributed equally to this work.